title: Commentary on the results and clinical implications of the PROactive study.
authors.affiliation: American Diabetes Association, 1701 N. Beauregard Street, Alexandria, VA 22311, USA. rkahn@diabetes.org
authors.forename: Robert
authors.initials: R
authors.lastname: Rizza
authors.forename: Robert
authors.initials: R
authors.lastname: Henry
authors.forename: Richard
authors.initials: R
authors.lastname: Kahn
mesh_terms: D000284:Administration, Oral; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D015203:Reproducibility of Results; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D010919:Placebos; D045162:Thiazolidinediones